Artificial intelligence (AI) and machine learning (ML) technologies are redefining the way biopharma companies discover and develop drugs. It’s not a passing phase, either. Half of the 50 biggest pharmaceutical companies have entered into partnerships or licensing agreements with AI companies in recent years. It’s clear that pharma companies are embracing AI in droves. The reasons why are simple: AI has the potential to revolutionize the drug discovery and development process, promising improved efficiency, accuracy, and speed. And according to Forbes, AI is slashing drug discovery costs for pharmaceutical companies by a whopping 70%. But how exactly is AI being used to transform drug discovery, and why does it matter?
Read the full article: AI Identification in the Drug Discovery Process //